Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Prestige Consumer Healthcare Community
NYSE:PBH Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Prestige Consumer Healthcare
Latest
Undervalued
Overvalued
Community Investing Ideas
Prestige Consumer Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Hydralyte's International Expansion Will Drive Future Success
Key Takeaways Strong international and North American growth through brands and innovation drives revenue and gross margin improvement. Debt reduction and strategic investments enhance financial flexibility, increasing EPS and supporting profitability through improved cash flow.
View narrative
US$86.67
FV
3.7% undervalued
intrinsic discount
2.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
PBH
PBH
Prestige Consumer Healthcare
Your Fair Value
US$
Current Price
US$83.44
22.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-82m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.2b
Earnings US$235.3m
Advanced
Set Fair Value